NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
1,488
Frequently Asked Questions
What is Market Cap of NovoCure Ltd?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. NovoCure Ltd market cap is $1.36B.
What is the 52-week high for NovoCure Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. NovoCure Ltd 52 week high is $34.13 as of September 16, 2025.
What is the 52-week low for NovoCure Ltd?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. NovoCure Ltd 52 week low is $10.87 as of September 16, 2025.
What is NovoCure Ltd stock price today?
NovoCure Ltd stock price today is $12.72.
What was NovoCure Ltd stock price yesterday?
NovoCure Ltd stock price yesterday was $12.15.
What is the PE ratio of NovoCure Ltd?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. NovoCure Ltd’s P/E ratio is -7.78.
What is the Price-to-Book ratio of NovoCure Ltd?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. NovoCure Ltd P/B ratio is 3.8872.
What is the 50-day moving average of NovoCure Ltd?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. NovoCure Ltd 50-day moving average is $13.30.